FLT3 mutations in myeloid sarcoma

British Journal of Haematology

Volumn 126, Issue 6, 2004, Pages 785-791

  Ansari Lari, M Ali ^a   Yang, Ching Fen ^a   Tinawi Aljundi, Rima ^a   Cooper, Lisa ^a   Long, Patricia ^a   Allan, Robert H ^a   Borowitz, Michael J ^a   Berg, Karin D ^a   Murphy, Kathleen M ^a,b  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b Carnegie Bldg ^*  (United States)

Author keywords

Acute myeloid leukaemia; FLT3; Molecular pathology; Mutation; Myeloid sarcoma

Indexed keywords

ASPARTIC ACID; CD135 ANTIGEN; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; BASE PAIRING; CANCER PATIENT; CLINICAL ARTICLE; CYTOGENETICS; FEMALE; GRANULOCYTIC SARCOMA; HUMAN; HUMAN TISSUE; INFANT; MALE; MOLECULAR BIOLOGY; MUTATIONAL ANALYSIS; MYELOID SARCOMA; MYELOPROLIFERATIVE DISORDER; POINT MUTATION; PRIORITY JOURNAL;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; FEMALE; FMS-LIKE TYROSINE KINASE 3; HUMANS; INFANT; LEUKEMIA, MYELOID; MALE; MIDDLE AGED; MUTATION; NEOPLASM PROTEINS; POINT MUTATION; PROTO-ONCOGENE PROTEINS; RECEPTOR PROTEIN-TYROSINE KINASES; TANDEM REPEAT SEQUENCES;

EID: 4644219519     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2004.05124.x     Document Type: Article

References (31)

1. Abu-Duhier, P.M., Goodeve, A.C., Wilson, G.A., Gari, M.A., Peake, I.R., Rees, D.C., Vandenberghe, E.A., Winship, P.R. & Reilly, J.T. (2000) FLT3 internal tandem duplication mutations in adult acute myeloid leukaemia define a high-risk group. British Journal of Haematology, 111, 190-195.
2. Abu-Duhier, F.M., Goodeve, A.C., Wilson, G.A., Care, R.S., Peake, I.R. & Reilly, J.T. (2001) Identification of novel FLT-3 Asp835 mutations in adult acute myeloid leukaemia. British Journal of Haematology, 113, 983-988.
3. Advani, S.H., Malhotra, H., Kadam, P.R., Iyer, R.S., Nanjangud, G., Balsara, B., Saikia, T., Gopal, R. & Nair, CN. (1991) T-lymphoid blast crisis in chronic myeloid leukemia. American Journal of Hematology, 36, 86-92.
4. Apfelbeck, U., Hoefler, G., Neumeister, P., Fonatsch, C., Linkesch, W. & Sill, H. (2000) Extramedullary T cell lymphoblastic transformation of chronic myeloid leukaemia successfully treated with matched unrelated donor bone marrow transplantation. Bone Marrow Transplantation, 26, 1111-1112.
5. Au, W.Y., Fung, A.T., Ma, E.S., Liang, R.H. & Kwong, Y.L. (2004) Low frequency of FLT3 gene internal tandem duplication and activating loop mutation in therapy-related acute myelocyticleukemia and myelodysplastic syndrome. Cancer Genetics and Cytogenetics, 149, 169-172.
6. Dusenbery, K.E., Howells, W.B., Arthur, D.C., Alonzo, T., Lee, J.W., Kobrinsky, N., Barnard, D.R., Wells, R.J., Buckley, J.D., Lange, B.J. & Woods, W.G. (2003) Extramedullary leukemia in children with newly diagnosed acute myeloid leukemia: a report from the Children's Cancer Group. Journal of Pediatric Hematology/Oncology, 25, 760-768.
7. Frohling, S., Schlenk, R.F., Breitruck, J., Benner, A., Kreitmeier, S., Tobis, K., Dohner, H. & Dohner, K. (2002) Prognostic significance of activating FLT3 mutations in younger adults (16 to 60 years) with acute myeloid leukemia and normal cytogenetics: a study of the AML Study Group Ulm. Blood, 100, 4372-4380.
8. Iwai, T., Yokota, S., Nakao, M., Okamoto, T., Taniwaki, M., Onodera, N., Watanabe, A., Kikuta, A., Tanaka, A., Asami, K., Sekine, I., Mugishima, H., Nishimura, Y., Koizumi, S., Horikoshi, Y., Mimaya, J., Ohta, S., Nishikawa, K., Iwai, A., Shimokawa, T., Nakayama, M., Kawakami, K., Gushiken, T., Hyakuna, N. & Fujimoto, T. (1999) Internal tandem duplication of the FLT3 gene and clinical evaluation in childhood acute myeloid leukemia. The Children's Cancer and Leukemia Study Group, Japan. Leukemia, 13, 38-43.
9. Jilani, I., Estey, E., Manshuri, T., Caligiuri, M., Keating, M., Giles, F., Thomas, D., Kantarjian, H. & Albitar, M. (2003) Better detection of FLT3 internal tandem duplication using peripheral blood plasma DNA. Leukemia, 17, 114-119.
10. Kiyoi, H., Naoe, T., Nakano, Y., Yokota, S., Minami, S., Miyawaki, S., Asou, N., Kuriyama, K., Jinnai, I., Shimazaki, C., Akiyama, H., Saito, K., Oh, H., Motoji, T., Omoto, E., Saito, H., Ohno, R. & Ueda, R. (1999) Prognostic implication of FLT3 and N-RAS gene mutations in acute myeloid leukemia. Blood, 93, 3074-3080.
11. Kottaridis, P.D., Gale, R.E., Frew, M.E., Harrison, G., Langabeer, S.E., Belton, A.A., Walker, H., Wheatley, K., Bowen, D.T., Burnett, A.K., Goldstone, A.H. & Linch, D.C. (2001) The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials. Blood, 98, 1752-1759.
12. Kottaridis, P.D., Gale, R.E., Langabeer, S.E., Frew, M.E., Bowen, D.T. & Linch, D.C. (2002) Studies of FLT3 mutations in paired presentation and relapse samples from patients with acute myeloid leukemia: implications for the role of FLT3 mutations in leukemogenesis, minimal residual disease detection, and possible therapy with FLT3 inhibitors. Blood, 100, 2393-2398.
13. Levis, M. & Small, D. (2003a) FLT3: it does matter in leukemia. Leukemia, 17, 1738-1752.
14. Levis, M. & Small, D. (2003b) Novel FLT3 tyrosine kinase inhibitors. Expert Opinion on Investigational Drugs, 12, 1951-1962.
15. Meis, J.M., Butler, J.J., Osborne, B.M. & Manning, J.T. (1986) Granulocytic sarcoma in nonleukemic patients. Cancer, 58, 2697-2709.
16. Moreno, I., Martin, G., Bolufer, P., Barragan, E., Rueda, E., Roman, J., Fernandez, P., Leon, P., Mena, A., Cervera, J., Torres, A. & Sanz, M.A. (2003) Incidence and prognostic value of FLT3 internal tandem duplication and D835 mutations in acute myeloid leukemia. Haematologica, 88, 19-24.
17. Murphy, K.M., Levis, M., Hafez, M.J., Geiger, T., Cooper, L.C., Smith, B.D., Small, D. & Berg, K.D. (2003) Detection of FLT3 internal tandem duplication and D835 mutations by a multiplex polymerase chain reaction and capillary electrophoresis assay. Journal of Molecular Diagnostics, 5, 96-102.
18. Neiman, R.S., Barcos, M., Berard, C., Bonner, H., Mann, R., Rydell, R.E. & Bennett, J.M. (1981) Granulocytic sarcoma: a clinicopathologic study of 61 biopsied cases. Cancer, 48, 1426-1437.
19. Noguera, N.I., Breccia, M., Divona, M., Diverio, D., Costa, V., De Santis, S., Avvisati, G., Pinazzi, M.B., Petti, M.C., Mandelli, F. & Lo Coco, F. (2002) Alterations of the FLT3 gene in acute promyelocytic leukemia: association with diagnostic characteristics and analysis of clinical outcome in patients treated with the Italian AIDA protocol. Leukemia, 16, 2185-2189.
20. Pardanani, A., Reeder, T.L., Kimlinger, T.K., Baek, J.Y., Li, C.Y., Butterfield, J.H. & Tefferi, A. (2003) Flt-3 and c-kit mutation studies in a spectrum of chronic myeloid disorders including systemic mast cell disease. Leukemia Research, 27, 739-742.
21. Peterson, L., Dehner, L.P. & Brunning, R.D. (1981) Extramedullary masses as presenting features of acute monoblastic leukemia. American Journal of Clinical Pathology, 75, 140-148.
22. Ridge, S.A. & Wiedemann, L.M. (1994) Chromosome 11q23 abnormalities in leukaemia. Leukemia and Lymphoma, 14, 11-17.
23. Schnittger, S., Schoch, C., Dugas, M., Kern, W., Staib, P., Wuchter, C., Loffler, H., Sauerland, C.M., Serve, H., Buchner, T., Haferlach, T. & Hiddemann, W. (2002) Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia: correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual disease. Blood, 100, 59-66.
24. Sheikhha, M.H., Awan, A., Tobal, K. & Liu Yin, J.A. (2003) Prognostic significance of FLT3 ITD and D835 mutations in AML patients. Hematology Journal, 4, 41-46.
25. Shih, L.Y., Huang, C.F., Wu, J.H., Lin, T.L., Dunn, P., Wang, P.N., Kuo, M.C., Lai, C.L. & Hsu, H.C. (2002) Internal tandem duplication of FLT3 in relapsed acute myeloid leukemia: a comparative analysis of bone marrow samples from 108 adult patients at diagnosis and relapse. Blood, 100, 2387-2392.
26. Thiede, C., Steudel, C., Mohr, B., Schaich, M., Schakel, U., Platzbecker, U., Wermke, M., Bornhauser, M., Ritter, M., Neubauer, A., Ehninger, G. & Illmer, T. (2002) Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis. Blood, 99, 4326-4335.
27. Whitman, S.P., Archer, K.J., Feng, L., Baldus, C., Becknell, B., Carlson, B.D., Carroll, A.J., Mrozek, K., Vardiman, J.W., George, S.L., Kolitz, I.E., Larson, R.A., Bloomfield, C.D. & Caligiuri, M.A. (2001) Absence of the wild-type allele predicts poor prognosis in adult de novo acute myeloid leukemia with normal cytogenetics and the internal tandem duplication of FLT3: a cancer and leukemia group B study. Cancer Research, 61, 7233-7239.
28. Wiernik, P.H. & Serpick, A.A. (1970) Granulocytic sarcoma (chloroma). Blood, 35, 361-369.
29. Yamamoto, Y., Kiyoi, H., Nakano, Y., Suzuki, R., Kodera, Y., Miyawaki, S., Asou, N., Kuriyama, K., Yagasaki, F., Shimazaki, C., Akiyama, H., Saito, K., Nishimura, M., Motoji, T., Shinagawa, K., Takeshita, A., Saito, H., Ueda, R., Ohno, R. & Naoe, T. (2001) Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies. Blood, 97, 2434-2439.
30. Yokota, S., Kiyoi, H., Nakao, M., Iwai, T., Misawa, S., Okuda, T., Sonoda, Y., Abe, T., Kahsima, K., Matsuo, Y. & Naoe, T. (1997) Internal tandem duplication of the FLT3 gene is preferentially seen in acute myeloid leukemia and myelodysplastic syndrome among various hematological malignancies. A study on a large series of patients and cell lines. Leukemia, 11, 1605-1609.
31. Zebisch, A., Cerroni, L., Beham-Schmid, C. & Sill, H. (2003) Therapy-related leukemia cutis: case study of an aggressive disorder. Annals of Hematology, 82, 705-707.